In murine adenocarcinoma cell lines that were transgenic for human d16HER2 or wtHER2 and ad hoc-engineered human MCF7 and T47D BC cell lines, the crucial function of the d16HER2 variant versus wtHER2 in HER2-positive BC stemness and aggressiveness has been demonstrated [58]. Here, ERBB2 is linked to breast cancer.